Adeptus Health Inc. (NYSE:ADPT) registered a -6.93% decrease, still its new closing price is -3.97% up from the company’s 1 year high of 73.44.It posted -8.34% losses in previous 5 sessions and is now the subject of 4 analysts who together assign a hold rating on stock. 1 of Wall Street analysts have an underperform rating; the 0 sells versus 0 buy or better ratings. The 7 stock analysts following this company have an average price target at $16.21, with individual PT in the $11.00-$31.00 range. The shares moved at $7.25, implying that brokerage firms see shares losing about -84.63% in twelve months time.
Adeptus Health Inc. (ADPT) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a -5.10% fall year to date. A Director, 10% Owner at Adeptus Health Inc. (ADPT) offloaded shares in a transaction closed on Wednesday June 08, 2016. Sterling Capital Partners III, sold 1,043,281 shares in the company at $60.53 each and collected $63,149,001 in proceeds. Sterling Capital Partners III, now owns 1,015,406 shares in the company after this transaction. A Director, 10% Owner in the company, Sterling Capital Partners III,, disclosed a transaction on Tuesday August 04, 2015 that ended up generating $127,155,000 from the sale of 1,264,723 shares at $100.54 per share.
Adeptus Health Inc. (NYSE:ADPT) Upcoming Results on Tap
Adeptus Health Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.26 in that period. Sales during the quarter are predicted to arrive at $95.65 million.
Earnings surprise history: Last quarter, the company posted approximately $85.37 million in revenue and EPS of $0.06. The mean forecast was for $89.99 million and $0.56 a share, respectively. One quarter earlier, revenue for the stock was at $100.17 million, with earnings at $0.48/share.
Adeptus Health Inc. (ADPT) Brokerage Update
Adeptus Health Inc. (ADPT) is in Goldman’s research list so their analyst rating change is noteworthy. These shares were downgraded to Neutral from Buy by Goldman, according to news reported on Friday November 04, 2016.Another important research note was issued by Jefferies on Wednesday November 02, 2016.The firm downgraded ADPT to Hold from Buy. Over the last six months and over the last three months, the shares of Adeptus Health Inc. (ADPT), have changed -83.73% and -75.60%, respectively.
